{"url":"https://lda.senate.gov/api/v1/filings/feb2c4fa-fb8d-417b-a39c-4a8349f9a072/","filing_uuid":"feb2c4fa-fb8d-417b-a39c-4a8349f9a072","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2020,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/feb2c4fa-fb8d-417b-a39c-4a8349f9a072/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ronald M. Jacobs, Partner","dt_posted":"2020-10-19T20:54:16.493000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Massachusetts Avenue NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":39941,"url":"https://lda.senate.gov/api/v1/registrants/39941/","house_registrant_id":31958,"name":"VENABLE LLP","description":"Law firm","address_1":"600 Massachusetts Avenue NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RONALD M. JACOBS","contact_telephone":"+1 202-344-4000","dt_updated":"2026-07-27T16:10:38.817219-04:00"},"client":{"id":204480,"url":"https://lda.senate.gov/api/v1/clients/204480/","client_id":1007728,"name":"SECURE TRANSFUSION SERVICES, INC. (STS)","general_description":"Improving the quality & availability of transfusable blood components.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-04-14"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Funding for specialty medical clinics and equipment, including in response to COVID-19","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55074,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"STUPAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Funding for specialty medical clinics and equipment, including in response to COVID-19","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55074,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"STUPAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}